UVB
Dead / Cancelled — Cancelled — Section 8 (as of 25 Jan 2003)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74236954
- Registration number
- 1970244
- Mark type
- Design + words
- Filed
- 13 Jan 1992
- Published for opposition
- 13 Oct 1992
- Registered
- 23 Apr 1996
- Attorney of record
- Rochelle D. Alpert
Goods and services
- Class 005 — Pharmaceuticals: hyperimmune intravenous immunoglobulins and vaccines used in the prevention and treatment of sepsis and infectious diseases associated with cystic fibrosis, cryptosporidiosis, cytomegalovirus, hepatitis B, varicella-zoster and HIV
Owner
- Univax Biologics, Inc., Rockville, MD, US
- Univax Biologics, Inc., Rockville, MD, US
- Univax Biologics, Inc., Rockville, MD, US
Prosecution history
- 25 Jan 2003 — CANCELLED SEC. 8 (6-YR)
- 23 Apr 1996 — REGISTERED-PRINCIPAL REGISTER
- 16 Feb 1996 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Feb 1996 — ASSIGNED TO EXAMINER
- 18 Jan 1996 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Nov 1995 — USE AMENDMENT FILED
- 09 Aug 1995 — SOU EXTENSION 5 GRANTED
- 03 Jul 1995 — SOU EXTENSION 5 FILED
- 03 Feb 1995 — SOU EXTENSION 4 GRANTED
- 27 Dec 1994 — SOU EXTENSION 4 FILED
- 13 Jun 1994 — SOU EXTENSION 3 GRANTED
- 09 May 1994 — SOU EXTENSION 3 FILED
- 03 Mar 1994 — SOU EXTENSION 2 GRANTED
- 21 Dec 1993 — SOU EXTENSION 2 FILED
- 12 Jul 1993 — SOU EXTENSION 1 GRANTED